Adaptin Bio, Inc. Retained Earnings
Adaptin Bio, Inc. (APTN) had Retained Earnings of -$11.64 million as of 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-28
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$11.64M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$10.44M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$9.29M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$7.92M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$11.64M S-1 · filed 2026-08-28 | |
| 2026-03-31 | -$10.44M POS AM · filed 2026-07-21 | |
| 2025-12-31 | -$9.29M S-1 · filed 2026-08-28 | |
| 2025-09-30 | -$7.92M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$6.25M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$4.73M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$4.12M S-1 · filed 2026-08-28 | -$274.56K 10-K · filed 2025-04-15 |
| 2024-09-30 | -$235.82K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$206.17K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$170.57K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$113.40K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$79.24K 10-Q · filed 2023-11-14 | |
| 2022-12-31 | -$27.80K 10-K · filed 2024-04-01 |